Mianyang Haoxiang Holdings Co., Ltd agreed to acquire a 7.63% stake in Suzhou MedicalSystem Technology Co., Ltd. from Weng Kang, Yan Huanghong, Wang Jianhua and Fu Hong for approximately CNY 340 million.
May 23, 2022
Share
Mianyang Haoxiang Holdings Co., Ltd agreed to acquire a 7.63% stake in Suzhou MedicalSystem Technology Co., Ltd. (SHSE:603990) from Weng Kang, Yan Huanghong, Wang Jianhua and Fu Hong for approximately CNY 340 million on May 23, 2022. Under the terms, Mianyang Haoxiang Holdings Co., Ltd will acquire 12,631,936 shares at a price of CNY 26.6 per share, representing 7.63% stake in Suzhou MedicalSystem. Weng Kang will sell 3.30% stake representing 5,468,190 shares, Yan Huanghong will sell 3.37% stake representing 5,569,798 shares, Wang Jianhua will sell 0.60% stake representing 993,216 shares, Fu Hong will sell 0.36% stake representing 600,732 shares in Suzhou MedicalSystem. As of May 25, 2022, the transaction has been approved by the State-owned Assets Supervision and Administration Commission of Mianyang on May 20, 2022.
Suzhou Medical System Techology Co Ltd is a company mainly engaged in development and sales of clinical medical management information system software products. The Company's products include two types. The DoCare series of clinical medical management information system application software mainly includes anesthesia clinical information system, intensive care clinical information system, pre-hospital emergency information system, blood purification information system and clinical path information system. Another type of products is the overall solution of clinical information, including the overall solution of Dorico digital operating room and the overall solution of Dorico digital emergency first aid platform.
Mianyang Haoxiang Holdings Co., Ltd agreed to acquire a 7.63% stake in Suzhou MedicalSystem Technology Co., Ltd. from Weng Kang, Yan Huanghong, Wang Jianhua and Fu Hong for approximately CNY 340 million.
SUZHOU MEDICALSYSTEM TECHNOLOGY CO., LTD. 
